RIPK3 Slams the Brake on Leukemogenesis Francis Ka-Ming Chan Cancer Cell Volume 30, Issue 1, Pages 7-9 (July 2016) DOI: 10.1016/j.ccell.2016.06.017 Copyright © 2016 Elsevier Inc. Terms and Conditions
Figure 1 RIPK3 and MLKL Mediate Cell Death and IL-1β Processing to Limit the Extent of FLT3-ITD-Induced Leukemogenesis In human AML, loss of RIPK3 and MLKL inhibit these processes, which results in a developmental block and enhanced survival of transformed immature progenitors. Cancer Cell 2016 30, 7-9DOI: (10.1016/j.ccell.2016.06.017) Copyright © 2016 Elsevier Inc. Terms and Conditions